NeoGenomics specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus for physicians to help them diagnose and treat cancer. Our multi-methodology assays are cancer-specific or broad-based and our NGS menu includes targeted RNA fusion profiles that detects common and novel fusions partners and liquid biopsy testing for lung cancer, pan-cancer and hematologic cancers. The RaDaR® assay is a personalized, tumor-informed technology for the detection of minimal residual disease (MRD) and recurrence.